Beta-Glucans
Beta-1,3/1,6 and beta-1,3/1,4 glucans
TL;DR
Two different molecules share this name. Oat and barley beta-glucan (1,3/1,4) has authorised health-claim evidence for lowering LDL cholesterol at 3 g/day. Yeast and mushroom beta-glucan (1,3/1,6) is an immune modulator with weaker, mostly upper-respiratory evidence at 250-500 mg/day.
Ideal For
- Mildly elevated LDL cholesterol (cereal form)
- Post-meal glucose management (cereal form)
- Frequent upper respiratory infections under physical stress (yeast form)
- Athletes in heavy training blocks (yeast form)
Avoid If
- Autoimmune disease, for the immune-stimulating yeast form
- Immunosuppressant therapy or transplant
- Yeast allergy, for Saccharomyces-derived products
- Difficulty swallowing, for bulk cereal fibre
Frequently Asked Questions
Which type should I buy?
Can I just eat oats?
Is the immune evidence as strong as the cholesterol evidence?
Is it safe with an autoimmune condition?
Overview
The single biggest error people make with beta-glucans is treating them as one supplement. The linkage geometry of the glucose backbone changes the molecule entirely. Oat and barley beta-glucan has a 1,3/1,4 structure that makes it highly viscous in solution — the basis for EFSA and FDA authorised claims that 3 g/day lowers blood cholesterol, one of very few supplement claims to clear a regulatory evidence bar. Yeast, shiitake and other fungal beta-glucans carry 1,3/1,6 branching that is recognised as a pathogen-associated pattern by Dectin-1 and complement receptor 3 on innate immune cells, priming rather than stimulating them. That immune literature is a mixture of good mechanistic work, promising trials on upper respiratory infection frequency in stressed populations such as marathon runners, and a great deal of overreach. Buying the wrong one for your goal means taking a fibre when you wanted an immune modulator, or the reverse.
How It Works
- Cereal 1,3/1,4: viscous gel traps bile acids, forcing hepatic cholesterol use
- Cereal form also slows gastric emptying and blunts glucose response
- Fungal 1,3/1,6: Dectin-1 recognition primes innate immune cells
- Priming rather than stimulation, so no chronic inflammatory activation
Quick Facts
- 1,3/1,4 for cholesterol, 1,3/1,6 for immunity — not interchangeable
- 3 g/day carries an authorised cholesterol health claim
- Yeast forms prime rather than stimulate innate immunity
- Immune forms are inappropriate in autoimmune disease
Benefits & Outcomes
Natural Killer Cell Activity
Reliably shifts NK markers in small trials; fewer infections is a weaker claim.
Macrophage Function
Beta-glucans are the most-studied macrophage primers — binding dectin-1 receptors to enhance pathogen recognition, with human trials showing fewer respiratory infections.
Mucosal Immunity
RCTs in athletes and stressed populations show fewer and shorter upper respiratory infections with yeast beta-glucans (250–500 mg/day).
Cholesterol Management
A rare supplement claim with regulatory-grade evidence behind it — 3 g/day of cereal beta-glucan reliably lowers LDL.
Supporting Research16 studies
Beta-glucans in higher fungi and their health effects
Rop O, Mlcek J, Jurikova T
Fungal beta-glucans including lentinan from shiitake show immunomodulatory and cholesterol-lowering activity in experimental and early clinical work.
β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application
Murphy EJ, Rezoagli E, Major I
Mushroom beta-glucans alter cytokine and NK-cell measures in human trials, but clinically meaningful outcomes such as infection rates are rarely reported.
The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials
Ho HV, Sievenpiper JL, Zurbau A +4 more
significantly lowered LDL-cholesterol
A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv
Ho HV, Sievenpiper JL, Zurbau A +4 more
significantly reduced LDL-C
Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial
Rioux-Labrecque V, Cossette M, Rufiange M +3 more
was not effective in reducing LDL cholesterol concentration
Efficacy of oats in dyslipidemia: a systematic review and meta-analysis
Li A, Gao J, Li Y +4 more
oat-based products may result in a large reduction in LDL-C
High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults
Wang Y, Harding SV, Eck P +4 more
HMW β-glucan rather than LMW β-glucan reduced circulating TC effectively
Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study
Yamada J, Hamuro J, Hatanaka H +2 more
SDG alleviated ongoing symptoms of Japanese cedar pollen-induced rhinorrhea
Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study
Kirmaz C, Bayrak P, Yilmaz O +1 more
Glucan may have a role as an adjunct to standard treatment
Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism
Wang Y, Harding SV, Thandapilly SJ +3 more
Increased bile acid synthesis after consumption of 3 g HMW β-glucan
Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults
Ibrügger S, Kristensen M, Poulsen MW +4 more
do not fully support the hypocholesterolemic effects
Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials
Whitehead A, Beck EJ, Tosh S +1 more
At least 3 g/day of oat beta-glucan lowered LDL cholesterol by about 0.25 mmol/L and total cholesterol by about 0.30 mmol/L compared with control.
Effects of fungal beta-glucans on health - a systematic review of randomized controlled trials
Vlassopoulou M, Yannakoulia M, Pletsa V +2 more
reduces the incidence and symptoms of cold, flu and other respiratory infections
The anti-infective effect of β-glucans in children
Wzorek-Łyczko K, Woźniak W, Piwowarczyk A +1 more
Ten out of twelve trials demonstrated the effectiveness of β-glucans
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yu J, et al.
Oat beta-glucan significantly reduced total and LDL cholesterol in hypercholesterolemic adults, with no significant change in HDL cholesterol or triglycerides.
Effects of orally administered yeast-derived beta-glucans: A review
Samuelsen ABC, Schrezenmeir J, Knutsen SH
Human trials of oral yeast beta-glucans report reduced incidence or severity of upper respiratory tract infection symptoms in some populations, but results are inconsistent across preparations.
Safety Information
Potential Side Effects
Cereal forms cause bloating, gas and fullness, especially when introduced quickly. Yeast forms are generally well tolerated; occasional gastrointestinal upset.
Contraindications
Immune-modulating 1,3/1,6 forms are inappropriate in autoimmune disease and after organ transplant. Introduce cereal fibre gradually with adequate fluid.
Drug Interactions
- Immunosuppressants — yeast beta-glucan may oppose their action
- Oral medications — cereal fibre can delay absorption; separate by two hours
- Diabetes medication — additive glucose lowering with cereal forms
Pregnancy & Breastfeeding
Pregnancy: Likely safe
Breastfeeding: Likely safe
Dosage Guidelines
Dosage Used in Studies
250-3000 mg
Best Time to Take
Cereal form with meals; yeast form in the morning on an empty stomach
Best Form
Match the source to the goal: oat or barley for lipids, yeast or mushroom for immune support
Bioavailability
Neither form is absorbed as intact polysaccharide; cereal acts in the gut lumen, while fungal forms are sampled by gut-associated immune tissue.
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| Typical range | 3 g/day cereal for lipids; 250-500 mg/day yeast for immunity | |
| Starting dose | 1 g/day cereal form, or 250 mg/day yeast form | |
| Timing | Cereal with meals, yeast in the morning fasted | |
| Assessment point | Cereal: repeat lipid panel at 8-12 weeks. Yeast: judge over a full infection season. |
Forms Compared
Oat/barley beta-glucan (1,3/1,4)
3 g/day for the authorised cholesterol claim
Yeast beta-glucan (1,3/1,6)
250-500 mg/day for immune support
Mushroom beta-glucan
Shiitake, maitake and reishi sources; dose varies widely by extract
Food & Timing
Cereal beta-glucan must be taken with the meal to gel with food. Yeast beta-glucan is typically taken fasted.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.